Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer

World Journal of Gastroenterology

Volumn 9, Issue 1, 2003, Pages 50-53

  Liu, Hui Jie ^a   Guo, Xiao Lin ^a   Dong, Ming ^a   Wang, Lan ^a   Yuan, Yuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN II;

ALLELE; ARTICLE; CANCER RISK; CHINA; CONTROLLED STUDY; FAMILY HISTORY; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; STOMACH CANCER;

EID: 0037439101     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i1.50     Document Type: Article

References (41)

1. Botterweck AAM, Van Den Brandt PA, Goldbohm RA. Vitamins carotenoids, dietary fiber, and the risk of gastric carcinoma: Results from a prospective study after 6.3 years of follow-up. Cancer 2000; 88: 737-748
2. Cai L, Yu SZ, Zhang ZF. Cytochrome P450 2E1 genetic polymorphism and gastric cancer in Changle, Fujian Province. World J Gastroenterol 2001; 7: 792-795
3. Ye WM, Yi YN, Luo RX, Zhou TS, Lin RT, Chen GD. Diet and gastric cancer: A case control study in Fujian Province, China. World J Gastroenterol 1998; 4: 516-518
4. Zhang ZF, Kurtz RC, Klimstra DS, Yu GP, Sun M, Harlap S, Marshall JR. Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis. Cancer Detect Prev 1999; 23: 357-367
5. Melato M, Sidari L, Rizzardi C, Kovac D, Stimac D, Baxa P, Jonjic N. Gastric epithelium proliferation in early Hp+ and Hp- gastritis: A flow cytometry study. Anticancer Res 2001; 21: 1347-1353
6. Marinone C, Martinetti A, Mestriner M, Seregni E, Geuna M, Ferrari L, Strola G, Bonardi L, Fea E, Bombardieri E. p53 evaluation in gastric mucosa of patients with chronic Helicobacter pylori infection. Anticancer Res 2001; 21: 1115-1118
7. Oue N, Shigeishi H, Kuniyasu H, Yokozaki H, Kuraoka K, Ito R, Yasui W. Promoter hypermethylation of MGMT is associated with protein loss in gastric carcinoma. Int J Cancer 2001; 93: 805-809
8. Deguchi R, Takagi A, Kawata H, Inoko H, Miwa T. Association between CagA+ Helicobacter pylori infection and p53, bax and transforming growth factor-beta-RII gene mutations in gastric cancer patients. Int J Cancer 2001; 91: 481-485
9. Yao XX, Yin L, Sun ZC. The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis. World J Gastroenterol 2002; 8: 586-590
10. Zhou Y, Gao SS, Li YX, Fan ZM, Zhao X, Qi YJ, Wei JP, Zou JX, Liu G, Jiao LH, Bai YM, Wang LD. Tumor suppressor gene p16 and Rb expression in gastric cardia precancerous lesions from subjects at a high incidence area in northern China. World J Gastroenterol 2002; 8: 423-425
11. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan C-C, Hothman N, Lanyon G, Martin M, Fraumeni Jr JF, Rabkin CS. Interleukin-1 polymorphism associated with increased risk of gastric cancer. Nature 2000; 404: 398-402
12. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH, Wei Q. Association between TNF-α promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-706
13. Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y, Wang X, Spitz MR, Wei Q. Polymorphisms of 5, 10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: A case-control study. Int J Cancer 2001; 95: 332-336
14. Liu MR, Pan KF, Li ZF, Wang Y, Deng DJ, Zhang L, Lu YY. Rapid screening mitochondrial DNA mutation by using denaturing high-performance liquid chromatography. World J Gastroenterol 2002; 8: 426-430
15. Pfutzer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615-623
16. Prkacin I, Novak B, Sertic J, Mrzljak A. Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus. Acta Med Croatica 2001; 55: 73-76
17. Wu MS, Huang SP, Chang YT, Lin MT, Shun CT, Chang MC, Wang HP, Chen CJ, Lin JT. Association of the -160 C a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 2002; 94: 1443-1448
18. Takezaki T, Gao CM, Wu JZ, Li ZY, Wang JD, Ding JH, Liu YT, Hu X, Xu TL, Tajima K, Sugimura H. hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer 2002; 99: 624-627
19. Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, Shimamoto F, Haruma K, Chayama K. p53 codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002; 100: 304-308
20. Tsukino H, Kuroda Y, Qiu D, Nakao H, Imai H, Katoh T. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma. Int J Cancer 2002; 100: 425-428
21. Zhang Z, Zhang X, Hou G, Sha W, Reynolds GP. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. J Psychiatr Res 2002; 36: 317-324
22. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002; 418: 320-323
23. Clark AG. Population genetics: Malaria variorum. Nature 2002; 418: 283-285
24. Feng Z, Curtis J, Minchella DJ. The influence of drug treatment on the maintenance of schistosome genetic diversity. J Math Biol 2001; 43: 52-68
25. Kageyama T, Ichinose M, Tsukada-Kato S, Omata M, Narita Y, Moriyama A, Yonezawa S. Molecular cloning of neonate/infant-specific pepsinogens from rat stomach mucosa and their expressional change during development. Biochem Biophys Res Commun 2000; 267: 806-812
26. Kageyama T. Pepsinogens, progastricsins, and prochymosins: Structure, function, evolution, and development. Cell Mol Life Sci 2002; 59: 288-306
27. Guo XL, Wang LE, Wang L, Dong M, Yuan Y. The significant of measuring serum Hp CagA on the high risk population in the high-risk area of gastric cancer. Shijie Huaren Xiaohua Zazhi 2001; 9: 595-596
28. Ohtaki Y, Azuma T, Konishi J, Ito S, Kuriyama M. Association between genetic polymorphism of the pepsinogen C gene and gastric body ulcer: The genetic predisposition is not associated with Helicobacter pylori infection. Gut 1997; 41: 469-474
29. Brenner H, Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88: 274-279
30. Kim JC, Kim HC, Roh SA, Koo KH, Lee DH, Yu CS, Lee JH, Kim TW, Lee HL, Beck NE, Bodmer WF. hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer. Cancer Detect Prev 2001; 25: 503-510
31. Bakir T, Can G, Erkul S, Siviloglu C. Stomach cancer history in the siblings of patients with gastric carcinoma. Eur J Cancer Prev 2000; 9: 401-408
32. Dhillon PK, Farrow DC, Vaughan TL, Chow WH, Risch HA, Gammon MD, Mayne ST, Stanford JL, Schoenberg JB, Ahsan H, Dubrow R, West AB, Rotterdam H, Blot WJ, Fraumeni JF Jr. Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer 2001; 93: 148-152
33. Kishi K, Kinoshita Y, Matsushima Y, Okada A, Maekawa T, Kawanami C, Watanabe N, Chiba T. Pepsinogen C gene product is a possible growth factor during gastric mucosal healing. Biochem Biophys Res Commun 1997; 238: 17-20
34. Fernandez R, Vizoso F, Rodriguez JC, Merino AM, Gonzalez LO, Quintela I, Andicoechea A, Truan N, Diez MC. Expression and prognostic significance of pepsinogen C in gastric carcinoma. Ann Surg Oncol 2000; 7: 508-514
35. Kikuchi S, Kurosawa M, Sakiyama T, Tenjin H, Miki K, Wada O, Inaba Y. Long-term effect of Helicobacter pylori infection on serum pepsinogens. Jpn J Cancer Res 2000; 91: 471-476
36. Fujisawa T, Kumagai T, Goto A, Fujimori K, Akamatsu T, Kiyosawa K. Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy. Nippon Rinsho 1999; 57: 101-106
37. Araki H, Miyazaki R, Matsuda T, Gejyo F, Koni I. Significance of serume pepsinogens and their relationship to Helicobacter pylori infection and histological gastritis in dialysis patients. Nephrol Dial Transplant 1999; 14: 2669-2675
38. Magnusson PKE, Enroth H, Eriksson I, Held M, Nyren O, Engstrand L, Hansson L-E, Gyllensten UB. Gastric cancer and human leukocyte antigen: Distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res 2001; 61: 2684-2689
39. Archimandritis A, Sougioultzis S, Foukas PG, Tzivras M, Davaris P, Moutsopoulos HM. Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication. Clin Exp Immunol 2000; 119: 464-471
40. Sakai T, Aoyama N, Satonaka K, Shigeta S, Yoshida H, Shinoda Y, Shirasaka D, Miyamoto M, Nose Y, Kasuga M. HLA-DQB1 locus and the development of atrophic gastritis with Helicobacter pylori infection. J Gastroenterol 1999; 34: 24-27
41. Yoshitake S, Okada M, Kimura A, Sasazuki T. Contribution of major histocompatibility complex genes to susceptibility and resistance in Helicobacter pylori related diseases. Eur J Gastroenterol Hepatol 1999; 11: 875-880